Akèy › Anplwayè › ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc.: Salè H-1B ak pajon
ReCode Therapeutics, Inc. depoze 10 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 10. Medyèn salè yo ofri a: $113,629.
Èske ReCode Therapeutics, Inc. pajone visa H-1B?
ReCode Therapeutics, Inc. depoze 10 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 14, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Scientist II | 2 | $135,000 |
| Senior Research Associate I, Gene Editing | 1 | $115,000 |
| Research Associate, Aerosol - Lipid Nano Particle | 1 | $79,560 |
| Senior Manager, IT Infrastructure and Security | 1 | $185,000 |
| Research Associate II | 1 | $90,000 |
| Senior Director, Formulations and Process Development | 1 | $148,408 |
| Research Associate II, Bioanalytical | 1 | $88,000 |
| Scientist I, In Vitro Pharmacology | 1 | $112,258 |
| Senior Research Associate I | 1 | $76,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $110,000 |
| FY2024 | 3 | $115,000 |
| FY2025 | 3 | $112,258 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Molecular and Cellular Biologists5
- Bioengineers and Biomedical Engineers2
- Biological Technicians2
- Computer and Information Systems Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Scientist I, In Vitro Pharmacology | $112,258–$130,000 Nivo II | Menlo Park, CA | Apr 14, 2025 | Oct 1, 2025 | Certifye |
| Senior Director, Formulations and Process Development | $148,408–$275,000 Nivo IV | Menlo Park, CA | Jun 4, 2024 | Oct 1, 2024 | Certifye |
| Research Associate II, Bioanalytical | $88,000 Nivo IV | Menlo Park, CA | May 3, 2024 | Oct 1, 2024 | Certifye |
| Scientist II | $130,000 Nivo III | Menlo Park, CA | Aug 4, 2023 | Oct 1, 2023 | Certifye |
| Research Associate II | $90,000 Nivo IV | Menlo Park, CA | Jul 11, 2023 | Jul 31, 2023 | Certifye |
| Research Associate, Aerosol - Lipid Nano Particle | $79,560 Nivo I | Menlo Park, CA | May 3, 2023 | Oct 1, 2023 | Certifye |
| Senior Manager, IT Infrastructure and Security | $185,000 Nivo II | Menlo Park, CA | Apr 21, 2023 | May 15, 2023 | Certifye |
| Scientist II | $140,000 Nivo IV | Menlo Park, CA | Apr 17, 2023 | May 1, 2023 | Certifye, apre retire |
| Senior Research Associate I, Gene Editing | $115,000 Nivo III | Menlo Park, CA | Mar 1, 2023 | Mar 13, 2023 | Certifye, apre retire |
| Senior Research Associate I | $76,000 Nivo II | Dallas, TX | May 24, 2022 | Oct 1, 2022 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).